BioSpace News Archive

Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2019 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Wednesday, Feb. 5

TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California.

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, today announced that it will present a company overview at the Biotech Showcase 2020 conference, taking place at the Hilton Union Square in San Francisco, CA.

AdaptHealth Corp. (NASDAQ:AHCO) (“AdaptHealth”), the third largest provider of home medical equipment (“HME”) in the United States, announced today that it has closed the previously announced acquisition of the Patient Care Solutions business from McKesson Corporation and named healthcare industry veteran Rodney Carson as President of the newly-formed AdaptHealth Patient Care Solutions (“AdaptHealth PCS”)

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has finalized the label design for its Tauri-Gummies™ product. Each jar of Tauri-Gummies™ contains 600mg of CBD Isolate (24 gumdrops per jar / 25mg CBD Isolate each).

Glaukos Corporation announced that its management is scheduled to participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020, at 8:00 a.m. PST in San Francisco.

AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate in the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference on Thursday, January 9, 2020, in New York, NY.

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the names of local and national charitable organizations the Company supported in 2019.

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time), in San Francisco, California.

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) (“Momenta” or the “Company”), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it is consolidating key financial and business functions under Young Kwon, Ph.D., Momenta’s Chief Business Officer.